Quick Take
Inspire Medical Systems (INSP) wants to raise $75 million in an IPO of its common stock.
The company sells an implantable neurostimulation device to treat sleep apnea.
INSP is growing topline revenues substantially, but financial results show only a gradual path to profitability.
Company & Technology
Maple Grove, MN-based Inspire Medical Systems was founded in 2007 to develop implantable neurostimulation technologies to treat Obstructive Sleep Apnea (OSA). The company’s proprietary Inspire system is the ‘first and only FDA-approved closed-loop neurostimulation technology which provides a safe and effective treatment for moderate to